From the Journals

Cellution Launches AmnioPlast 1, AmnioPlast Double for Ocular Surface Repair

Both grafts are processed aseptically to preserve the native architecture of the amnion while eliminating the need for cryopreservation.

Share

Cellution Biologics Inc. has launched AmnioPlast 1 and AmnioPlast Double, innovative dehydrated human amnion membrane allografts designed for ocular surface applications. These grafts aim to assist in repair and reconstruction procedures for ocular diseases, eliminating the need for cryopreservation while maintaining the amnion's native architecture. Both products are minimally manipulated and harvested from healthy donor placentas, ensuring safety and sterility for use in clinical and surgical settings.

Original Source(s)

Cellution Launches AmnioPlast 1, AmnioPlast Double for Ocular Surface Repair

Both grafts are processed aseptically to preserve the native architecture of the amnion while eliminating the need for cryopreservation.

  • by Conexiant News Staff

  • November 23, 2025

  • 1 min

Related Content

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

CLINICAL: Cornea

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

  • November 1, 2019

  • 2 min
AOA Advocates for Optometry in the One Big Beautiful Bill Act

Their successes, areas for continued monitoring, exclusions, and next steps